Firms Planning EU Trials Should Seek Qualified NBs – RAPS Speaker
This article was originally published in The Gray Sheet
Manufacturers planning to conduct a clinical trial in Europe should contract with a notified body that offers experts in their area of study, according to Joris Bannenberg, COO and medical director of Dutch contract research firm Factory-CRO
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.